High mobility group box‐1 recognition: The beginning of a RAGEless era?
Open Access
- 17 June 2010
- journal article
- research article
- Published by EMBO in EMBO Molecular Medicine
- Vol. 2 (6), 193-195
- https://doi.org/10.1002/emmm.201000077
Abstract
High mobility group box 1 (HMGB1) is a molecular alarm signal that triggers an immune response when released. It was assumed that the receptor for advanced glycation end‐products (RAGE) would mediate the signal to the immune system. Recently pattern recognition receptors that are triggered by molecules of bacterial origin (the Toll‐like receptor (TLR) family) were shown to also respond to HMGB1. Now two papers establish the TLR4–HMGB1 axis as proinflammatory, eventually leading to disparate conditions like seizures or skin cancer. These reports add a new twist to our understanding of the mode of action of the alarm signal HMGB1.This publication has 5 references indexed in Scilit:
- Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizuresNature Medicine, 2010
- HMGB1 and RAGE in Inflammation and CancerAnnual Review of Immunology, 2010
- HMGB1 loves companyJournal of Leukocyte Biology, 2009
- HMGB1: Endogenous Danger SignalingMolecular Medicine, 2008
- Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin)Journal of Leukocyte Biology, 2006